Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arq Bras Oftalmol ; 81(1): 53-58, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29538595

RESUMO

PURPOSE: To investigate the potential effects of chronic exposure to a nasal decongestant and its excipients on ocular tissues using an experimental rat model. METHODS: Sixty adult male Wistar rats were randomized into six groups. The first two groups were control (serum physiologic) and Otrivine® groups. The remaining four groups received the Otrivine excipients xylometazoline, benzalkonium chloride, sorbitol, and ethylene diamine tetra acetic acid. Medications were applied into both nostrils twice a day for 8 weeks. Before the rats were sacrificed, epithelial staining, the Schirmer test, and intraocular pressure measurements were performed under ketamine/xylasine anesthesia (50 and 5 mg/kg, respectively). RESULTS: Epithelial defects and dry eye were common findings in all study groups. Cataracts developed in two cases clinically. Histopathological evaluation revealed many different pathological alterations in all parts of the ocular tissues such as corneal edema, polypoid proliferation and hyalinization of the vessel wall, cystic formation of the lens, retinal nerve fiber layer degeneration, and corpora amylacea formation of the lacrimal gland. CONCLUSIONS: Prolonged usage of the nasal decongestant xylometazoline and its excipients may cause ophthalmic problems such as dry eyes, corneal edema, cataracts, retinal nerve fiber layer, and vascular damage in rats. Although these results were obtained from experimental animals, ophthalmologists should keep in mind the potential ophthalmic adverse effects of this medicine and/or its excipients and exercise caution with drugs containing xylometazoline, ethylene diamine tetra acetic acid, benzalkonium chloride and sorbitol for patients with underlying ocular problems.


Assuntos
Oftalmopatias/induzido quimicamente , Olho/efeitos dos fármacos , Imidazóis/efeitos adversos , Descongestionantes Nasais/efeitos adversos , Mucosa Nasal/efeitos dos fármacos , Animais , Compostos de Benzalcônio/efeitos adversos , Modelos Animais de Doenças , Ácido Edético/efeitos adversos , Olho/patologia , Oftalmopatias/patologia , Pressão Intraocular , Masculino , Mucosa Nasal/patologia , Distribuição Aleatória , Ratos Wistar , Índice de Gravidade de Doença
2.
Arq. bras. oftalmol ; 81(1): 53-58, Jan.-Feb. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-888181

RESUMO

ABSTRACT Purpose: To investigate the potential effects of chronic exposure to a nasal decongestant and its excipients on ocular tissues using an experimental rat model. Methods: Sixty adult male Wistar rats were randomized into six groups. The first two groups were control (serum physiologic) and Otrivine® groups. The remaining four groups received the Otrivine excipients xylometazoline, benzalkonium chloride, sorbitol, and ethylene diamine tetra acetic acid. Medications were applied into both nostrils twice a day for 8 weeks. Before the rats were sacrificed, epithelial staining, the Schirmer test, and intraocular pressure measurements were performed under ketamine/xylasine anesthesia (50 and 5 mg/kg, respectively). Results: Epithelial defects and dry eye were common findings in all study groups. Cataracts developed in two cases clinically. Histopathological evaluation revealed many different pathological alterations in all parts of the ocular tissues such as corneal edema, polypoid proliferation and hyalinization of the vessel wall, cystic formation of the lens, retinal nerve fiber layer degeneration, and corpora amylacea formation of the lacrimal gland. Conclusions: Prolonged usage of the nasal decongestant xylometazoline and its excipients may cause ophthalmic problems such as dry eyes, corneal edema, cataracts, retinal nerve fiber layer, and vascular damage in rats. Although these results were obtained from experimental animals, ophthalmologists should keep in mind the potential ophthalmic adverse effects of this medicine and/or its excipients and exercise caution with drugs containing xylometazoline, ethylene diamine tetra acetic acid, benzalkonium chloride and sorbitol for patients with underlying ocular problems.


RESUMO Objetivo: Investigar os possíveis efeitos da exposição crônica de descongestionante nasal e seus excipientes em tecidos oculares, utilizando um modelo experimental com ratos. Métodos: Sessenta ratos Wistar adultos machos foram divididos aleatoriamente em seis grupos. Os primeiros dois grupos foram controle (soro fisiológico) e Otrivina®. Os quatro grupos restantes receberam os excipientes de Otrivina, tais como Xilometazolina, Benzalcônio, Sorbitol e Ácido Etilenodiamino Tetracético (EDTA). Os medicamentos foram aplicados em ambas as narinas dos ratos, duas vezes ao dia, durante 8 semanas. Antes que os ratos fossem sacrificados, a coloração epitelial, o teste de Schirmer e a medida da pressão intraocular foram realizados sob anestesia com Ketamina/Xilasina (50 e 5 mg/kg, respectivamente). Resultados: Defeitos epiteliais e olho seco foram achados comuns nos grupos de estudo. A catarata desenvolveu-se clinicamente em dois casos. A avaliação histopatológica revelou a existência de alterações em todas as partes dos tecidos oculares, tais como edema de córnea, proliferação polipoide e hialinização da parede vascular, formação cística da lente, degeneração da camada de fibra nervosa da retina (RNFL) e formação de corpos amiláceos da glândula lacrimal. Conclusões: O uso prolongado do descongestionante nasal Xilometazolina e seus excipientes pode causar vários problemas oftalmológicos, como olho seco, edema de córnea, catarata, RNFL e dano vascular em ratos. Embora esses resultados tenham sido obtidos a partir de animais experimentais, os oftalmologistas devem ter em mente os potenciais efeitos oftalmológicos adversos desse medicamento e/ou de seus excipientes.


Assuntos
Animais , Masculino , Descongestionantes Nasais/efeitos adversos , Olho/efeitos dos fármacos , Oftalmopatias/induzido quimicamente , Imidazóis/efeitos adversos , Mucosa Nasal/efeitos dos fármacos , Compostos de Benzalcônio/efeitos adversos , Índice de Gravidade de Doença , Distribuição Aleatória , Ácido Edético/efeitos adversos , Ratos Wistar , Modelos Animais de Doenças , Olho/patologia , Oftalmopatias/patologia , Pressão Intraocular , Mucosa Nasal/patologia
3.
Ecotoxicol Environ Saf ; 72(7): 1999-2004, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19497619

RESUMO

Subchronic toxicity of composite inorganic fertilizers such as ammonium sulfate [fertilizer A; (NH(4))(2)SO(4); 21% NH(4)-N)], composite fertilizer 15-15-15 (fertilizer B; commercial formulation: 15% NH(4)-N, 15% phosphorus, and 15% potassium oxide), and composite fertilizer 25-5-10 (fertilizer C; commercial formulation: 25% NH(4)-N, 5% phosphorus, and 10% potassium oxide) on the skin, liver, kidney, pancreas, and gills of the juvenile rainbow trout (Oncorhynchus mykiss) was studied in two-week toxicity tests under static-renewal test conditions. Fish exposed to sublethal concentrations of fertilizers did not show any behavioral abnormality compared to control groups. Histological lesions were observed in skin, gills, liver, pancreas, and trunk kidney of the fish. In the epidermis, degenerated/vacuolated epithelial cells, microcystic dilatations, and intracellular edema of mucus cell were observed. Liver had swollen and degenerated hepatocytes without losing adenoid structure. Hematopoietic tissues had necrosis and vacuolar degeneration on proximal tubules of the kidney. In order, the most affected organs were skin, liver, and kidney.


Assuntos
Fertilizantes/toxicidade , Brânquias/patologia , Rim/patologia , Fígado/patologia , Compostos de Nitrogênio/toxicidade , Oncorhynchus mykiss , Pele/patologia , Poluentes Químicos da Água/toxicidade , Animais , Relação Dose-Resposta a Droga , Brânquias/efeitos dos fármacos , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Oncorhynchus mykiss/crescimento & desenvolvimento , Pele/efeitos dos fármacos , Testes de Toxicidade Crônica
4.
J Vet Med Sci ; 66(9): 1137-42, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15472481

RESUMO

An eighteen month old female Doberman pinscher dog was referred to teaching hospital of Adnan Menderes University, Faculty of Veterinary Medicine with the complaint of right forelimb lameness for a month. On the basis of clinical, radiographical, scintigraphical, computed tomographical and histopathological findings, aneurysmal bone cyst was diagnosed. Surgical curettage and bone cement treatment were applied. The patient recovered after 12 months. This case proves that aneurysmal bone cyst, without osteolysis and/or damages to the surrounding tissues, may result in a good prognosis if curettage and treatment with bone cement are done.


Assuntos
Cimentos Ósseos/uso terapêutico , Cistos Ósseos Aneurismáticos/veterinária , Doenças do Cão/patologia , Doenças do Cão/terapia , Animais , Cistos Ósseos Aneurismáticos/patologia , Cistos Ósseos Aneurismáticos/terapia , Curetagem/veterinária , Cães , Feminino , Membro Anterior/diagnóstico por imagem , Radiografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...